Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan as Adjunct to SSRIs in Major Depressive Disorder
NCT05181527Phase 4Completed
- Sponsor
- AIIMS New Delhi
- Start
- Feb 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dextromethorphan in major depressive disorder (MDD), sponsored by AIIMS New Delhi. Started Feb 2022; status: completed.
02
Drugs
dextromethorphan
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05181527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05181527.